Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Motoyoshi Y
Paradoxical effects of KB-R7943 on arrhythmogenicity in a chronic myocardial infarction rabbit model
Smiles: COC1=CC2SC(=CC=2C=C1OC)C(=O)CCC(O)=O
MLN8054 exhibits the activity of growth inhibition across various cell lines from diverse tissue origins with IC50 values ranging from 0
Posaconazole is a triazole antifungal drug marketed in the United States by Schering-Plough under the trade name Noxafil
K-7174 Size:Solid 2 mg Motoyoshi YK 7174 is a novel orally active, potent proteasome inhibitor. K 7174 exerts anti myeloma activity in vitro and in vivo by down regulating the expression of class I histone deacetylases. K 7174 kills bortezomib resistant myeloma cells carrying a 5 subunit mutation in vivo and primary cells from a patient resistant to bortezomib. K 7174 is also a GATA specific inhibitor, which may have potential application in treating anemia of chronic disease. Product